دورية أكاديمية
أعرض في EDS

An Overview of Nanoparticle Protein Corona Literature.

التفاصيل البيبلوغرافية
العنوان: An Overview of Nanoparticle Protein Corona Literature.
المؤلفون: Hajipour MJ; Department of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA.; Department of Radiology, Stanford University, Stanford, CA, 94304, USA., Safavi-Sohi R; Department of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA.; Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN, 46556, USA., Sharifi S; Department of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA., Mahmoud N; Department of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA.; Faculty of Pharmacy, Al-Zaytoonah University of Jordan, Airport Rd., 11733, Amman, Jordan.; Department of Biomedical Sciences, College of Health Sciences, QU Health, Qatar University, Doha, 2713, Qatar., Ashkarran AA; Department of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA., Voke E; Department of Chemical and Biomolecular Engineering, University of California, Berkeley, CA, 94720, USA., Serpooshan V; Wallace H. Coulter Department of Biomedical Engineering, Emory University School of Medicine and Georgia Institute of Technology, Atlanta, GA, 30322, USA.; Department of Pediatrics, Emory University, Atlanta, GA, 30322, USA.; Children's Healthcare of Atlanta, Atlanta, GA, 30322, USA., Ramezankhani M; School of Engineering, University of British Columbia, Kelowna, BC, V1V 1V7, Canada., Milani AS; School of Engineering, University of British Columbia, Kelowna, BC, V1V 1V7, Canada., Landry MP; Department of Chemical and Biomolecular Engineering, University of California, Berkeley, CA, 94720, USA.; Innovative Genomics Institute, Berkeley, CA, 94720, USA.; California Institute for Quantitative Biosciences, University of California Berkeley, Berkeley, CA, 94720, USA.; Chan Zuckerberg Biohub, San Francisco, CA, 94158, USA., Mahmoudi M; Department of Radiology and Precision Health Program, Michigan State University, East Lansing, MI, 48824, USA.
المصدر: Small (Weinheim an der Bergstrasse, Germany) [Small] 2023 Sep; Vol. 19 (36), pp. e2301838. Date of Electronic Publication: 2023 Apr 29.
نوع المنشور: Journal Article; Review; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Wiley-VCH Country of Publication: Germany NLM ID: 101235338 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1613-6829 (Electronic) Linking ISSN: 16136810 NLM ISO Abbreviation: Small Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Weinheim, Germany : Wiley-VCH, c2005-
مواضيع طبية MeSH: Protein Corona*/chemistry , Nanoparticles*/chemistry , Metal Nanoparticles*, Reproducibility of Results ; Proteins/chemistry ; Nanomedicine
مستخلص: The protein corona forms spontaneously on nanoparticle surfaces when nanomaterials are introduced into any biological system/fluid. Reliable characterization of the protein corona is, therefore, a vital step in the development of safe and efficient diagnostic and therapeutic nanomedicine products. 2134 published manuscripts on the protein corona are reviewed and a down-selection of 470 papers spanning 2000-2021, comprising 1702 nanoparticle (NP) systems is analyzed. This analysis reveals: i) most corona studies have been conducted on metal and metal oxide nanoparticles; ii) despite their overwhelming presence in clinical practice, lipid-based NPs are underrepresented in protein corona research, iii) studies use new methods to improve reliability and reproducibility in protein corona research; iv) studies use more specific protein sources toward personalized medicine; and v) careful characterization of nanoparticles after corona formation is imperative to minimize the role of aggregation and protein contamination on corona outcomes. As nanoparticles used in biomedicine become increasingly prevalent and biochemically complex, the field of protein corona research will need to focus on developing analytical approaches and characterization techniques appropriate for each unique nanoparticle formulation. Achieving such characterization of the nano-bio interface of nanobiotechnologies will enable more seamless development and safe implementation of nanoparticles in medicine.
(© 2023 The Authors. Small published by Wiley-VCH GmbH.)
References: Chem Rev. 2015 Oct 14;115(19):11147-90. (PMID: 26088284)
Nanoscale. 2015 May 21;7(19):8978-94. (PMID: 25920546)
Nature. 2018 May;557(7707):613. (PMID: 29795524)
Nat Rev Mater. 2021;6(12):1078-1094. (PMID: 34394960)
Nat Rev Mater. 2021;6(12):1072-1074. (PMID: 34642607)
J Control Release. 2015 Nov 10;217:345-51. (PMID: 26264835)
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22639-22648. (PMID: 32900936)
Sci Transl Med. 2019 Jan 30;11(477):. (PMID: 30700577)
J Am Chem Soc. 2011 Mar 2;133(8):2525-34. (PMID: 21288025)
Nat Nanotechnol. 2018 Sep;13(9):777-785. (PMID: 30190620)
Bioconjug Chem. 2020 Sep 16;31(9):2046-2059. (PMID: 32786370)
Nat Rev Drug Discov. 2021 Feb;20(2):101-124. (PMID: 33277608)
Nat Nanotechnol. 2021 Jun;16(6):617-629. (PMID: 34117462)
Nat Commun. 2022 Jan 10;13(1):49. (PMID: 35013179)
Nat Cancer. 2020 Sep;1(9):882-893. (PMID: 34447945)
J Liposome Res. 2005;15(1-2):109-39. (PMID: 16194930)
Nat Commun. 2022 Nov 3;13(1):6610. (PMID: 36329043)
Proc Natl Acad Sci U S A. 2022 Feb 22;119(8):. (PMID: 35173043)
Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14265-70. (PMID: 18809927)
ACS Nano. 2013 Aug 27;7(8):6555-62. (PMID: 23808533)
Nat Nanotechnol. 2021 Mar;16(3):229-242. (PMID: 33597736)
Adv Healthc Mater. 2020 Mar;9(5):e1901608. (PMID: 31994348)
J Control Release. 2022 May;345:819-831. (PMID: 35346768)
ACS Nano. 2017 Mar 28;11(3):2313-2381. (PMID: 28290206)
Nat Nanotechnol. 2020 Apr;15(4):313-320. (PMID: 32251383)
Nat Nanotechnol. 2017 Apr 6;12(4):288-290. (PMID: 28383044)
Curr Top Microbiol Immunol. 2022;440:71-110. (PMID: 32483657)
Biomater Sci. 2018 Sep 25;6(10):2656-2666. (PMID: 30140818)
Nat Commun. 2021 Jan 25;12(1):573. (PMID: 33495475)
Adv Healthc Mater. 2021 Jan;10(1):e2001378. (PMID: 33236524)
Trends Biotechnol. 2018 Aug;36(8):755-769. (PMID: 29559165)
Nat Commun. 2021 Sep 2;12(1):5246. (PMID: 34475383)
Nat Commun. 2021 May 20;12(1):2984. (PMID: 34017011)
Nanoscale. 2019 Oct 28;11(40):18806-18824. (PMID: 31595922)
Sci Rep. 2018 Feb 1;8(1):2178. (PMID: 29391566)
Nat Nanotechnol. 2012 Dec;7(12):779-86. (PMID: 23212421)
Nanoscale. 2018 Apr 19;10(15):7108-7115. (PMID: 29616243)
Bioeng Transl Med. 2019 Sep 05;4(3):e10143. (PMID: 31572799)
Cancer Res. 2019 Apr 1;79(7):1624-1634. (PMID: 30692215)
Nanoscale. 2020 May 14;12(18):10240-10253. (PMID: 32356537)
Nano Today. 2019 Oct;28:. (PMID: 32774443)
Nat Rev Mater. 2023 Mar 24;:1-17. (PMID: 37361608)
Nat Protoc. 2014 Sep;9(9):2030-44. (PMID: 25079427)
Biomater Sci. 2014 Sep 29;2(9):1210-1221. (PMID: 32481892)
Biochemistry. 1969 Oct;8(10):4149-58. (PMID: 5346393)
J Am Chem Soc. 2010 Apr 28;132(16):5761-8. (PMID: 20356039)
Nat Nanotechnol. 2019 Jul;14(7):629-635. (PMID: 31270452)
Proc Natl Acad Sci U S A. 2007 Feb 13;104(7):2050-5. (PMID: 17267609)
J Am Chem Soc. 2022 Mar 23;144(11):4746-4753. (PMID: 35263098)
Proc Natl Acad Sci U S A. 2021 Dec 28;118(52):. (PMID: 34933999)
معلومات مُعتمدة: R01 DK131417 United States DK NIDDK NIH HHS
فهرسة مساهمة: Keywords: analytical chemistry; characterization; nanomedicine; protein corona; reproducibility; standard procedures
المشرفين على المادة: 0 (Protein Corona)
0 (Proteins)
تواريخ الأحداث: Date Created: 20230429 Date Completed: 20230907 Latest Revision: 20231006
رمز التحديث: 20240628
مُعرف محوري في PubMed: PMC10552659
DOI: 10.1002/smll.202301838
PMID: 37119440
قاعدة البيانات: MEDLINE
الوصف
تدمد:1613-6829
DOI:10.1002/smll.202301838